FRESHPET, INC. (FRPT): what the price requires

Generated: 2026-07-19 · Source: https://boothcheck.com/report/FRPT

Headline

Field	Value
Ticker	FRPT
Company	FRESHPET, INC.
Current price	$55.50/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	whole-company
Operating margin today	3.2%
Must persist for	13.9y
Multiple paid	79x operating income

Solve inputs: computed at a 9.5% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.3 years.

How unusual the bet is: high

Reference	Value
cohort percentile (of 69 peers)	100
sustained it ~10 years at this level	14%
implied end-window share	0%

Valuation X-Ray

The price is supported by asset-based and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	1.19x	4	expensive
Earnings	1.35x	3	expensive
Relative	1.21x	5	expensive
Growth	1.00x	3	justifies

Families that justify the price: Asset, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.1%); the inversion above states its own rate.

Per-Model Detail (n=15)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	$55.77	1.00x	yes	FCF base $0.1B, growth 12% (input: historical growth), terminal g 4.0%, WACC 8.1%, 6yr projection
DCF Exit Multiple	Growth	$62.95	0.88x	yes	Exit EV/EBITDA: 15.3x / 17.3x / 19.3x (bear / base = today's held flat / bull), 6yr
Relative Valuation	Relative	$66.28	0.84x	yes	P/E 22x (static sector reference · 2026-04), scenarios: 18.1x / 22.0x / 25.9x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDM	Growth	—	—	no	—
Two-Stage DDM	Growth	—	—	no	—
Simple Excess Return	Asset	$38.63	1.44x	yes	BV/sh $22.51, ROE (TTM) 15.9%, ke 9.3%
Two-Stage Excess Return	Asset	$49.97	1.11x	yes	5yr excess ROE then converge to ke=9.3%
Discounted Future Market Cap	Growth	$49.10	1.13x	yes	Rev $1.1B, growth 12% (input: historical growth; tapered), Terminal P/S: 2.3x / 2.7x / 3.2x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair Value	Relative	$45.72	1.21x	yes	EPS $3.81, growth 2% (input: historical EPS growth), PEG=7.76 (Overvalued)
Margin Trajectory	Growth	—	—	no	—
Earnings Power Value	Earnings	$0.01	5550.00x	yes	Normalized EBIT (5y avg op income, one-time charges added back) $0.00B × (1−26%) / WACC 8.1% → EPV (no growth) (excluded from median)
Residual Income	Asset	$50.87	1.09x	yes	BV $22.51 + 5yr PV of (ROE (TTM) 15.9% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham Number	Asset	$43.93	1.26x	yes	√(22.5 × EPS $3.81 × BVPS $22.51) — Graham's conservative floor
EV/EBITDA Relative	Relative	$44.56	1.25x	yes	EBITDA $0.18B × sector EV/EBITDA 14.0x
FCF Yield	Earnings	$7.54	7.36x	yes	FCF $46.8M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF Yield	Earnings	$2.34	23.72x	yes	SBC-adj FCF $0.02B (FCF $0.05B − SBC $0.03B) capitalized at Kₑ (excluded from median)
Ben Graham Formula	Earnings	$122.94	0.45x	yes	EPS $3.81 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/B	Asset	$0.66	84.09x	yes	BV $22.51 × (ROIC 0.2% / WACC 8.1%) (excluded from median)
P/Sales Sector	Relative	$40.54	1.37x	yes	Revenue $1.14B × sector P/S 2.0x
PEG Fair Value	Relative	$142.88	0.39x	yes	EPS $3.81 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings Yield	Earnings	$41.19	1.35x	yes	EPS $3.81 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Net debt	$45.9m
Net debt / NOPAT (after-tax)	1.75x
Net debt / operating income (pre-tax)	1.29x
Interest coverage	2.5x
Share count CAGR (dilution)	4.0%
Burning cash	no

Bullet Takeaways

• Freshpet sells fresh, refrigerated pet food through its own branded fridges in more than 30,000 retail stores, and the model is now scaling profitably: first-quarter net sales rose 13.1% to $297.6 million and the company swung to a $48.5 million net profit from a year-earlier loss.
• The biggest risk is that the price already credits years of continued growth and margin expansion, while the company still spends heavily on plant capacity, guiding to roughly $150 million of capital expenditure in 2026 that holds free cash flow thin.
• Watch household penetration, which the 10-K puts at about 15.2 million U.S. households, since the runway for continued volume growth is the assumption the valuation rests on.

Bull Case

The trajectory is the story. Freshpet just put up first-quarter net sales of $297.6 million, up 13.1% year over year, and the composition of that growth is the part that matters: volume rose 14.6%, partially offset by a slightly unfavorable price and mix. Growth driven by selling more units rather than charging more per unit is the healthiest kind, because it means the brand is winning new customers and new occasions, not squeezing existing ones. Gross margin expanded to 40.5% from 39.4%, and the bottom line flipped from a year-earlier net loss of $12.7 million to a net profit of $48.5 million. A company that grows volume in the mid-teens while expanding margin and crossing into sustained profitability is demonstrating operating leverage in real time.

The business model is genuinely differentiated, and the moat is physical. Freshpet sells fresh, refrigerated pet food, a category it effectively created, and it controls the point of sale through its own branded refrigerators placed in retailers. The 10-K reports the products were in approximately 30,235 retail stores as of the end of 2025. Each branded fridge is a small piece of owned real estate inside a competitor's store, a constant in-aisle advertisement, and a barrier that a packaged-goods rival cannot replicate without convincing retailers to give up more cold space. That installed base is why the brand can keep adding households faster than the category grows.

The runway is the bull's strongest card. The 10-K states that "our household penetration within the United States was approximately 15.2 million households, and adds that "there are opportunities to expand our network into international markets as demonstrated by our initiatives in the U.K. market. Roughly 15 million households is a fraction of U.S. pet-owning homes, which means the volume engine has years of penetration left before it saturates. Management raised full-year 2026 net sales growth guidance to 8% to 11% and reiterated adjusted EBITDA of $205 million to $215 million, with the company now expecting positive free cash flow even as it invests about $150 million in capacity. The shift from cash-burning expansion to self-funding growth is the inflection the bull case has been waiting for.

Bear Case

The bear case is about what the price already assumes. At $55.01 (June 27, 2026), the stock embeds a long runway of continued growth and a sustained climb in operating margin from today's roughly 8% level. The inversion of the price requires that improvement to play out over more than a decade. That is a specific, fragile assumption: the price is not paying for the business as it earns today, it is paying for the business management promises to build, year after year, without a stumble. Trailing earnings power, capitalized as it stands, supports a far lower number, and the methods that anchor on current free cash flow land in the single digits because so much of the operating cash is consumed by plant construction.

Capital intensity is the mechanism that makes that fragile. Freshpet's growth requires building refrigerated manufacturing capacity, and the 10-K notes that "due to limited manufacturing capacity and our continued growth, the Company recently expanded its manufacturing capacity and may in the future continue to do so. The 2026 plan calls for roughly $150 million of capital expenditure. That spending is what keeps free cash flow thin even as reported profit rises, and it means the company must keep growing fast enough to justify the plants it is building. If volume growth slows toward the low end of guidance, the company is left with expensive capacity and a valuation built on a faster ramp than it is delivering. Share count has also been rising at about 6.6% a year, so per-share progress lags the headline growth.

Competition is the third pressure, and it works through price. Freshpet sits at a premium price point against mass-market kibble and canned food from far larger rivals. The 10-K is direct about the danger: the company faces "competition from competitors' products that are sometimes sold at lower prices. Price gaps between our products and our competitors' products may result in market share erosion, and it notes that several competitors have "broader product lines, substantially greater financial and other resources. The slightly negative price and mix in the most recent quarter is a small but real sign that pricing power has limits. In a softer consumer environment, a premium pet-food brand is exactly the kind of discretionary trade-down candidate that loses volume to cheaper shelves. The price assumes that does not happen.

Valuation

What the price is betting on is durability of growth, not the current earnings stream. The methods split in an informative way. The asset-based methods, built from book value of about $22.51 per share and a trailing return on equity near 16%, sit below the price but within range. The relative-multiple methods, using a consumer-sector earnings multiple, land near or slightly below the price. The forward-growth methods reach the price by crediting continued double-digit growth. And the earnings-power methods that capitalize current free cash flow collapse to almost nothing, because Freshpet's free cash flow is small after the heavy capital spending. That last set is the outlier rather than the signal: it reflects a company deliberately reinvesting ahead of growth, not a business without earnings.

The coherent read is that this is a growth-stage consumer story wearing a mature label, and the price asks the buyer to underwrite the growth continuing for a long time. The most concrete way to frame the bet: at today's price the operating margin, around 8% now, has to climb meaningfully and the volume engine has to keep running for well over a decade. That is plausible given household penetration of about 15.2 million homes and a category Freshpet effectively owns, but it is a long assumption with no margin for a stall. The forward methods that reach the price do so by holding today's growth and multiple roughly flat across the forecast, which is the question rather than the answer.

Solvency is not the worry here. Net debt is modest at about $46 million against trailing operating income near $92 million, leaving interest coverage above 6 times, and the company holds substantial liquidity. The balance sheet comfortably funds the capacity expansion. The decisive variable is execution on growth and margin: the valuation is reasonable if the ramp continues as guided and stretched if it slows. The shift to positive free cash flow in the 2026 outlook is the milestone that would make the growth self-funding and the price easier to defend.

Catalysts

Freshpet reported first-quarter 2026 results in May, with net sales of $297.6 million, up 13.1%, driven by volume gains of 14.6% partially offset by unfavorable price and mix of 1.5%. Gross margin rose to 40.5% from 39.4%, and the company posted net income of $48.5 million against a year-earlier net loss of $12.7 million, with adjusted EBITDA of $37.9 million. The swing to profitability on volume-led growth was the central takeaway.

Management raised full-year 2026 net sales growth guidance to 8% to 11%, up from a prior 7% to 10%, and reiterated adjusted EBITDA of $205 million to $215 million. The company expects approximately $150 million of capital expenditure for the year and, notably, positive free cash flow, the marker of the transition from cash-consuming expansion to self-funded growth.

The developments to watch are the pace of household penetration and distribution gains, particularly in club and mass channels and the early U.K. international expansion, alongside the trajectory of margin as the newly added manufacturing capacity comes online and absorbs fixed cost. The next earnings report will show whether the volume momentum and the margin expansion both held, which together are what the valuation depends on.

Peer Cohorts (Per Segment, With Filing Citations)

Freshpet (single operating segment) (reported)

• CENT (Central Garden & Pet Company)
• FY2025 10-K: …finance, legal, human resources, and information technology functions. Operating Income Operating income improved $64.7 million, or 34.9%, to $250.0 million in fiscal 2025. Operating income improved due to a $53.6 million increase in gross profit, related to a 240-basis point increase in gross margin, and a $11.1…
• FY2025 10-K: …maker uses operating income or loss to evaluate segment performance and allocate resources, including consideration of plan-to-actual variances and prior year-to-actual variances on a quarterly basis. The Company's Corporate expenses are included in the following presentation since certain expenses are not allocated…
• GIS (GENERAL MILLS INC)
• FY2025 10-K: …the Pet segment to the North America Pet segment to reflect that pet food results outside North America are recorded in the International segment. There were no changes to the composition of our reportable segments or information reviewed by our CODM and no impact on our historical segment operating results. Our…
• FY2025 10-K: …may not foot due to rounding. Constant-currency Segment Operating Profit Growth Rates We believe that this measure provides useful information to investors because it provides transparency to underlying performance of our segments by excluding the effect that foreign currency exchange rate fluctuations have on…
• LW (Lamb Weston Holdings, Inc.)
• FY2025 10-K: Condition and Results of Operations" and Note 13, Segments, of the Notes to Consolidated Financial Statements in "Part II, Item 8. Financial Statements and Supplementary Data" of this Form 10-K. North America Our North America segment primarily includes frozen potato products sold in the United States, Canada, and…
• FY2025 10-K: Farm Owned (1), Leased (2) Hermiston, OR Production Facility Owned (1) Park Rapids, MN (a) Production Facility and Cold Storage Owned (1) Pasco, WA Production Facility (2) Owned (2) Paterson, WA Production Facility, Farm (4) Owned (2), Leased (3) Quincy, WA Production Facility Owned (1) Richland, WA Production…
• MZTI (The Marzetti Company)
• FY2025 10-K: …to the completion of our ERP implementation in 2024. Beginning in 2025, these ongoing costs are no longer classified separately as Project Ascent expenses. Restructuring and Impairment Charges In 2025, we committed to a plan to close our sauce and dressing production facility in Milpitas, California as part of our…
• FY2025 10-K: …in Retail; • demonstrated success with strategic licensing programs in Retail through both new and established relationships in the foodservice industry; • recognized leadership in Foodservice product development; • experience in integrating complementary business acquisitions; and • historically strong cash flow…
• JJSF (J&J SNACK FOODS CORP.)
• FY2025 10-K: Chief Operating Decision Maker reviews and evaluates capital spending of each segment on a quarterly basis to monitor cash flow and asset needs of each segment. Additionally, our Chief Operating Decision Maker considers variances of actual performance to our annual operating plan and periodic forecasts when making…
• FY2025 10-K: …make soft pretzels which are extruded or shaped by hand. Soft pretzels, after baking, are quick-frozen and packaged for delivery. The Company's principal marketing program in the Food Service segment includes supplying ovens, mobile merchandisers, display cases, warmers, and similar merchandising equipment to the…
• BRBR (BellRing Brands, Inc.)
• FY2025 10-K: …in the subsidiaries of BellRing LLC. Post had acquired the businesses that comprised its active nutrition business in a series of transactions during 2013, 2014 and 2015. In its fiscal year ended September 30, 2013, Post acquired Premier Nutrition Corporation, which, at the time, was a marketer and distributor of…
• FY2025 10-K: …$ 2.2 of accrued excise tax payments that had been accrued for in prior fiscal years. "Purchases of treasury stock" in the Consolidated Statements of Cash Flows for the years ended September 30, 2024 and 2023 excluded $ 1.4 and $ 0.8 , respectively, of accrued excise tax that had not been paid as of September 30,…
• FLO (FLOWERS FOODS, INC)
• FY2025 10-K: 10-K FY false 0001128928 2025 http://fasb.org/srt/2025#ChiefExecutiveOfficerMember one year one month three years http://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpense --01-05 http://www.flowersfoods.com/20260103#NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponentExcludingSettl…
• FY2025 10-K: Internal Control Over Financial Reporting: Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act. Under the supervision and with the participation of our management, including our CEO and our…
• TR (TOOTSIE ROLL INDUSTRIES INC)
• FY2025 10-K: …a "step zero" test of its goodwill and certain trademarks, and concluded that there was no impairment based on this guidance. Although the "step-zero" analysis performed for the fair value assessment of certain trademarks concluded that there was no impairment, the Company proceeded to "step-one" and performed…
• FY2025 10-K: …and relief-from-royalty method. ​ The Company has no accumulated impairment losses of goodwill. ​ NOTE 13-LEASES: ​ The Company leases certain buildings, land and equipment that are classified as operating leases. These leases have remaining lease terms of up to approximately 16 years . Operating lease cost totaled $…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 results, May 2026 · FY2025 10-K · Q1 2026 results release, May 2026 · 2026 guidance, May 2026